Future of psoriasis: An industry perspective on research

Expert Review of Dermatology

Volumn 3, Issue 4 SUPPL 1, 2008, Pages

  Malefyt, R de Waal ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CNTO 1275; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 23;

AUTOIMMUNITY; BASAL CELL CARCINOMA; BRAIN INFARCTION; CD4+ T LYMPHOCYTE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG MECHANISM; HEART INFARCTION; HELPER CELL; HUMAN; IMMUNOMODULATION; LYMPHOCYTE DIFFERENTIATION; MEDICAL RESEARCH; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSORIASIS; RISK FACTOR; SINGLE DRUG DOSE; SQUAMOUS CELL CARCINOMA; TH17 CELL;

EID: 55349129598     PISSN: 17469872     EISSN: None     Source Type: Journal    
DOI: 10.1586/17469872.3.4.S13     Document Type: Conference Paper

References (9)

1. Krueger GG, Langley RG, Leonardi C et al. A human interleukin-12/ 23 monoclonal antibody for the treatment of psoriasis. N. Engl. J. Med. 356, 580-592 (2007).
2. Toichi E, Torres G, McCormick TS et al. An anti-IL-12p40 antibody down-regulates type 1 cytokines, chemokines, and IL-12/IL-23 in psoriasis. J. Immunol. 177, 4917 (2006).
3. Cargill M, Schrodi SJ, Chang M et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am. J. Hum. Genet. 80, 273-290 (2007).
4. Capon F, Di Meglio P, Szaub J et al. Sequence variants in the genes for the interleukin-23 receptor (IL-23R) and its ligand (IL-12B) confer protection against psoriasis. Hum. Genet. 122, 201-206 (2007).
5. Wilson NJ, Boniface K, Chan JR et al. Development, cytokine profile and function of human interleukin-17 producing T cells. Nat. Immunol. 8, 950-957 (2007).
6. Homey B, Dieu-Nosjean MC, Wiesenborn A et al. Up-regulation of macrophage inflammatory protein-3 α/CCL20 and CC chemokine receptor 6 in psoriasis. J. Immunol. 164, 6621-6632 (2000).
7. Teunissen MB, Koomen CW, de Waal Malefyt R, Wierenga EA, Bos JD. Interleukin-17 and interferon-γ synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. J. Invest. Dermatol. 111, 645-649 (1998).
8. Wolk K, Witte E, Wallace E et al. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur. J. Immunol. 36, 1309-1323 (2006).
9. Chan JR, Blumenschein W, Murphy E et al. IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis. J. Exp. Med. 203, 2577-2587 (2006).